• 中国资本市场开放出大招 跨境证券投资更便利 2019-10-13
  • 世卫将“游戏障碍”列为新疾病 哪些症状可被确诊? 2019-10-13
  • 景区去门票化积弊短期难除 如何摆脱门票依赖? 2019-10-08
  • 东风路老旧小区欲华丽变身 微改造项目勘察设计已招标 ——凤凰网房产广州 2019-10-08
  • 翔龙无人机服役后首次曝光,大幅提升空军情报收集能力 2019-09-19
  • 证监会去年对外公开监管信息14560条 2019-09-19
  • 人民网欧洲中心分社记者报道集 2019-09-06
  • 图解:短视频平台频遭约谈敲响警钟,野蛮生长要不得! 2019-09-06
  • 中考期间广州部分公交线路有调整 2019-09-01
  • 减肥必备!这十种食物饱口福还能吃出好身材 2019-09-01
  • “蛟龙” 吸引世界目光(砥砺奋进的五年·重大工程巡礼) 2019-08-19
  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置时时彩网络平台>技术资料首页>行业动态>公司动态>PPD公司任命Lee E. Babiss为全球实验室服务部门执行副总裁

    时时彩后一杀号大全: PPD公司任命Lee E. Babiss为全球实验室服务部门执行副总裁

    PPD2010年2月24日 19:56 点击:3083

    美国PPD Pharmaceutical Product Development, Inc

    PPD公司任命Lee E. Babiss为全球实验室服务部门执行副总裁

    时时彩网络平台 www.qlgr.net 2010-02-24 15:03

    北卡罗来纳州威明顿--(美国商业资讯)--PPD公司(PPD, Inc.,纳斯达克股票代码:PPDI)今天宣布,任命Lee E. Babiss博士为全球实验室服务部门执行副总裁。他将为公司的生物分析、动态药品生产管理规范(cGMP)、全球中心实验室、疫苗和生物制剂业务、以及 PPD在去年收购的位于中国的药品研发服务公司保诺科技(BioDuro)提供战略方向以及其他科学方面的指导。

    PPD公司首席运营官William Sharbaugh说:"Babiss博士拥有超过21年的开发和领导研发实验室的经验。由于我们不断通过全球实验室提供特殊的科学知识,并推广最先进的设施以满足日益增长的客户需求,Babiss博士的战略领导能力将十分宝贵。我很高兴有Lee这样有才干的领导人和科学家加入我们的团队。"

    在此之前,Babiss博士在瑞士巴塞尔担任霍夫曼-拉罗奇有限公司(F. Hoffmann-La Roche, Ltd)的总裁和药品研究部总监。他的职责包括指引全球实验室的研发工作,研发领域包括:化学、开发技术、治疗性蛋白质、基于RNA的疗法、非临床安全、技术科学和信息学。他支持肿瘤学、神经学、炎症、病毒学和代谢领域的药品研发工作,并是该公司药品经营和战略投资委员会成员。

    在加入霍夫曼-拉罗奇公司之前,Babiss博士曾在葛兰素公司(现称葛兰素史克公司)任职七年。在葛兰素公司,他逐渐被晋升到责任更为重大的职位,包括生物科学和遗传学副总裁。在任职期间,他负责在全球范围内开发和执行公司的企业战略,并致力于以细胞循环为重点的遗传学和肿瘤研究工作。

    Babiss博士获得了哥伦比亚大学微生物学博士学位,并完成了洛克菲勒大学的博士后研究工作。在洛克菲勒大学他担任助理和副教授职务。Babiss博士多次获得奖学金和助学金,并就职于数个科学咨询委员会和理事会。

    PPD是一家领先的全球性合同研究组织,从事研发服务已达25年。我们的客户及合作伙伴包括制药、生物技术、医疗器械、学术及政府机构。PPD依靠在40个国家设立的分支机构和遍布全球的10,500多名专业人才,运用创新技术和专业治疗经验,秉承坚定的质量承诺,帮助客户及合作伙伴获得最大的研发投资回报,使安全有效的疗法更快应用于患者。如需了解更多信息,请访问我们的网站:www.ppdi.com。

    除历史事实性信息之外,本新闻发布稿中所含各项陈述、预期和假设,包括上述员工的业绩以及为PPD和全球实验室所作贡献的预期和假设,均属前瞻性陈述,其内容涉及一系列风险和不确定性。尽管PPD力图准确表述这些前瞻性陈述,但今后的情形仍然有可能与此类陈述所依据的假设产生差异。此外,其他一些可能导致实际结果产生显著差异的重要因素有:吸引、凝聚和留住核心人才的能力;外包行业内的竞争;迅猛的技术发展致使我们产品和服务的竞争力下降;销售增长方面取得的成功;失去大订单;高订单撤销率;制药、生物技术、医疗器械、学术及政府行业细分市场的经济环境和外包趋势;因依赖某些合作关系而带来的相关风险;与药物的开发和商业化有关的风险,包括收益摊薄以及获取监管批准的风险;资产减损等一些与收购及投资有关的风险;我们可能无法继续执行股利策略的风险;以及PPD向美国证券交易委员会呈报的文件中不时列出的其他风险因素,这些文件的副本可向PPD投资者关系部门免费索取。

     

    免责声明:本公告之原文版本乃官方授权版本。译文仅供方便了解之用,烦请参照原文,原文版本乃唯一具法律效力之版本。

     

    联系方式:

    PPD公司
    媒体:
    Sue Ann Pentecost, 919-456-5890
    [email protected]

    分析师/投资者:
    Luke Heagle, 910-558-7585
    [email protected]


    PPD新闻稿

    PPD Names Lee E. Babiss Executive Vice President of Global Laboratory Services

     

    WILMINGTON, N.C. (February 22, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Lee E. Babiss, Ph.D., as executive vice president of global laboratory services. He will provide strategic direction and additional scientific leadership to the company's bioanalytical, cGMP and global central laboratories, vaccines and biologics operations and to BioDuro, the China-based drug discovery services company PPD acquired last year.

    "Dr. Babiss brings more than 21 years of experience developing and leading research and development laboratories," said William Sharbaugh, chief operating officer of PPD. "His strategic leadership will be valuable as we continue to deliver exceptional scientific expertise across our global labs and expand our state-of-the-art facilities to meet growing client demand. I am pleased to have a leader and scientist of Lee's caliber join our team."

    Dr. Babiss most recently served as president and director of pharmaceutical research for F. Hoffmann-La Roche, Ltd., in Basel, Switzerland. His responsibilities included leading global laboratory functions in chemistry, discovery technologies, therapeutic proteins, RNA-based therapeutics, non-clinical safety, technical sciences and informatics. He supported drug discovery efforts in oncology, neurosciences, inflammation, virology and metabolism and was a member of the company's pharma executive and strategic portfolio committees.

    Prior to joining Hoffmann-La Roche, Dr. Babiss spent seven years with Glaxo Inc., now GlaxoSmithKline, where he was promoted to positions of increasing responsibility, including vice president of biological sciences and genetics. In this role, he had global accountability for developing and implementing the company's corporate genetics strategy and oncology research efforts focused on the cell cycle.

    Dr. Babiss earned a doctorate in microbiology from Columbia University and completed his postdoctoral fellowship at The Rockefeller University where he served as an assistant and associate professor. He has received numerous fellowship awards and grants and serves on several scientific advisory committees and boards.

    PPD is a leading global contract research organization, celebrating 25 years of providing discovery and development services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 40 countries and more than 10,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and commitment to quality to help clients and partners maximize returns on R&D investments that accelerate the delivery of safe, effective therapeutics. For more information, visit www.ppdi.com.

    Except for historical information, all of the statements, expectations and assumptions contained in this news release, including expectations and assumptions about the above-named employee's performance and contributions to PPD and its laboratory businesses, are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based. In addition, other important factors which could cause results to differ materially include the following: the ability to attract, integrate and retain key personnel; competition within the outsourcing industry; rapid technological advances that make our products and services less competitive; success in sales growth; loss of large contracts; high cancellation rates; economic conditions and outsourcing trends in the pharmaceutical, biotechnology, medical device, academic and government industry segments; risks associated with and dependence on collaborative relationships; risks associated with the development and commercialization of drugs, including earnings dilution and obtaining regulatory approval; risks associated with acquisitions and investments, such as impairments; risks that we may not continue our dividend policy; and the other risk factors set forth from time to time in the SEC filings for PPD, copies of which are available free of charge upon request from the PPD investor relations department.

    Contacts
    Media:
    Sue Ann Pentecost
    +919 456 5890
    [email protected]

    Analysts/Investors:
    Luke Heagle
    +910 558 7585
    [email protected]

    (来源: PPD )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, 时时彩网络平台,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


  • 中国资本市场开放出大招 跨境证券投资更便利 2019-10-13
  • 世卫将“游戏障碍”列为新疾病 哪些症状可被确诊? 2019-10-13
  • 景区去门票化积弊短期难除 如何摆脱门票依赖? 2019-10-08
  • 东风路老旧小区欲华丽变身 微改造项目勘察设计已招标 ——凤凰网房产广州 2019-10-08
  • 翔龙无人机服役后首次曝光,大幅提升空军情报收集能力 2019-09-19
  • 证监会去年对外公开监管信息14560条 2019-09-19
  • 人民网欧洲中心分社记者报道集 2019-09-06
  • 图解:短视频平台频遭约谈敲响警钟,野蛮生长要不得! 2019-09-06
  • 中考期间广州部分公交线路有调整 2019-09-01
  • 减肥必备!这十种食物饱口福还能吃出好身材 2019-09-01
  • “蛟龙” 吸引世界目光(砥砺奋进的五年·重大工程巡礼) 2019-08-19
  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 内蒙古快三跨度和直走势图 福建时时彩开到几点 江西快3开奖 福彩3d跨度走势图彩经网 足球半全场玩法 南粤风采26选5开奖结果查询今天 3d帝国彩票论坛 排列三和排列五走势图 围棋的玩法 东方6十1开奖兑奖 三肖中特期期准337888cc 幸运赛车视频直播 2019新表十二生肖图 龙江体彩6十奖金累 福彩3d近100期开奖结果